Most Read Articles
Roshini Claire Anthony, 09 Oct 2020

The risk of falls and subsequent injuries (eg, fractures) may be elevated in individuals with diabetes compared with the general population, according to a nationwide cohort study from Denmark.

Audrey Abella, 10 Sep 2020
Interim results of REGENERATE* trial highlight the ability of experimental noninvasive tests to evaluate treatment response in adults with NASH** and advanced liver fibrosis who are receiving obeticholic acid (OCA).
Rachel Soon, 28 Aug 2020
MOH Director-General Tan Sri Dato' Seri Dr Noor Hisham Abdullah speaks about NHMS 2019 and pharmacists' roles in combating NCDs among Malaysians.
Jairia Dela Cruz, 23 Sep 2020
The combination of pitavastatin and fenofibrate appears to have superior effect on non-high-density lipoprotein cholesterol (non–HDL-C), as well as other lipids, compared with a statin alone in high-risk patients with mixed dyslipidemia, according to a study.

Insulin beneficial to pregnant women with triglyceride-rich lipoproteins

15 Oct 2020

Women with high levels of very low-density lipoprotein (VLDL) cholesterol or high apolipoprotein B to A-1 ratio (apoB/apoA-1) may fare better with insulin than metformin, with a recent study showing that treatment with the latter leads to higher serum concentrations of triglyceride-rich lipoproteins in the last trimester of pregnancy.

In addition, offspring birth weight tends to increase with higher triglyceride and cholesterol content in VLDL particles.

Researchers conducted a secondary analysis of a randomized trial evaluating the effect of metformin (n=110) vs insulin (n=107) in the treatment of women with gestational diabetes mellitus (GDM) to analyse the associations between individual lipids and offspring birth weight.

Age, prepregnancy body mass index, fasting glucose, HbA1c, and gestational weight gain, among others, were similar in the two treatment groups. Likewise, there were no significant between-group differences seen in absolute mean and adjusted birth weight in children. The incidence of small or large for gestational age was likewise not significantly different.

At 36 gestational weeks, total and VLDL triglycerides and VLDL cholesterol rose from baseline. However, the increase in triglycerides was greater in the metformin-treated group (p<0.01).

Baseline total and VLDL triglycerides, VLDL cholesterol, and apoB/apoA-1 showed a positive association with birth weight, and these relationships were more pronounced in the metformin group.

Among patients in the highest baseline VLDL cholesterol or apoB/apoA-1 quartile, those treated with insulin gave birth to infants with smaller birth weight than those treated with metformin (p<0.03).

Larger studies are needed to confirm the results of the study.

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Pharmacist - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Roshini Claire Anthony, 09 Oct 2020

The risk of falls and subsequent injuries (eg, fractures) may be elevated in individuals with diabetes compared with the general population, according to a nationwide cohort study from Denmark.

Audrey Abella, 10 Sep 2020
Interim results of REGENERATE* trial highlight the ability of experimental noninvasive tests to evaluate treatment response in adults with NASH** and advanced liver fibrosis who are receiving obeticholic acid (OCA).
Rachel Soon, 28 Aug 2020
MOH Director-General Tan Sri Dato' Seri Dr Noor Hisham Abdullah speaks about NHMS 2019 and pharmacists' roles in combating NCDs among Malaysians.
Jairia Dela Cruz, 23 Sep 2020
The combination of pitavastatin and fenofibrate appears to have superior effect on non-high-density lipoprotein cholesterol (non–HDL-C), as well as other lipids, compared with a statin alone in high-risk patients with mixed dyslipidemia, according to a study.